Where do Monopar Therapeutics's ratios come from?

Every ratio is computed from Monopar Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

	FY'25	FY'24	FY'23	FY'22
Returns
Return on equity	-14.2%+37.2pp	-51.4%+55.8pp	-107.2%-34.7pp	-72.4%-19.9pp
Return on assets	-13.6%+32.4pp	-46.1%+35.6pp	-81.7%-19.4pp	-62.3%-13.6pp
Efficiency
Asset turnover	0×—	0×—	0×—	——
Liquidity
Current ratio	51.4×+39.9×	11.5×+7.3×	4.2×0.0×	4.2×-8.8×
Quick ratio	51.4×+39.9×	11.5×+7.3×	4.2×0.0×	4.2×-8.8×
Cash ratio	22.6×+13.9×	8.7×+4.6×	4.1×+1.5×	2.6×-10.2×
Leverage
Debt-to-equity	0×—	——	0×0.0×	0×—
Debt-to-assets	0×—	——	0×0.0×	0×—
Valuation
Market capitalization	$587.04M+192%	$134.17M+2,553%	$5.06M-83.5%	$30.62M-24.2%
Enterprise value	$534.72M+232%	——	-$2.2M-110%	$22.49M—
Price / book	4.3×+0.6×	2.4×+1.5×	0.9×-2.1×	3×+0.9×
Earnings yield	-2.6%+5.7pp	-11.6%+155pp	-166.1%-132pp	-34.3%-11.8pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Monopar Therapeutics's ratios come from?: Every ratio is computed from Monopar Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.